Discussion Paper to Explore Managing Validation Activities of CMOs

Pharmaceutical manufacturers need to carefully plot out how they are going to manage the validation activities with their manufacturing partners. Not planning out these activities before the knowledge transfer can raise the ire of FDA.

Managing the validation activities of contract manufacturing organizations requires considerable planning by pharmaceutical manufacturers.

An industry group has recommended that marketing authorization holders, or MAHs, need to draft a comprehensive set of documents and...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from United States

More from North America